Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11721388rdf:typepubmed:Citationlld:pubmed
pubmed-article:11721388lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:11721388lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:11721388lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:11721388lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:11721388lifeskim:mentionsumls-concept:C1414481lld:lifeskim
pubmed-article:11721388lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:11721388lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:11721388lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:11721388lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:11721388pubmed:issue6lld:pubmed
pubmed-article:11721388pubmed:dateCreated2001-11-27lld:pubmed
pubmed-article:11721388pubmed:abstractTextTo synthesize antisense oligodeoxynucleotides (AS) targeting the fusion point region (FUAS) and the start codon region (STAS) of the long type PML-RAR alpha mRNA and investigate its stability, specificity and effects on the growth and apoptosis of NB4 cells.lld:pubmed
pubmed-article:11721388pubmed:languagechilld:pubmed
pubmed-article:11721388pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11721388pubmed:citationSubsetIMlld:pubmed
pubmed-article:11721388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11721388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11721388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11721388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11721388pubmed:statusMEDLINElld:pubmed
pubmed-article:11721388pubmed:monthJunlld:pubmed
pubmed-article:11721388pubmed:issn0253-2727lld:pubmed
pubmed-article:11721388pubmed:authorpubmed-author:ChenYYlld:pubmed
pubmed-article:11721388pubmed:authorpubmed-author:ZiaMMlld:pubmed
pubmed-article:11721388pubmed:authorpubmed-author:MiaoJJlld:pubmed
pubmed-article:11721388pubmed:issnTypePrintlld:pubmed
pubmed-article:11721388pubmed:volume20lld:pubmed
pubmed-article:11721388pubmed:ownerNLMlld:pubmed
pubmed-article:11721388pubmed:authorsCompleteYlld:pubmed
pubmed-article:11721388pubmed:pagination303-6lld:pubmed
pubmed-article:11721388pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11721388pubmed:meshHeadingpubmed-meshheading:11721388...lld:pubmed
pubmed-article:11721388pubmed:meshHeadingpubmed-meshheading:11721388...lld:pubmed
pubmed-article:11721388pubmed:meshHeadingpubmed-meshheading:11721388...lld:pubmed
pubmed-article:11721388pubmed:meshHeadingpubmed-meshheading:11721388...lld:pubmed
pubmed-article:11721388pubmed:meshHeadingpubmed-meshheading:11721388...lld:pubmed
pubmed-article:11721388pubmed:meshHeadingpubmed-meshheading:11721388...lld:pubmed
pubmed-article:11721388pubmed:meshHeadingpubmed-meshheading:11721388...lld:pubmed
pubmed-article:11721388pubmed:meshHeadingpubmed-meshheading:11721388...lld:pubmed
pubmed-article:11721388pubmed:year1999lld:pubmed
pubmed-article:11721388pubmed:articleTitle[Design and synthesis of anti-PML-RAR alpha antisense and its effects on the growth and apoptosis of NB4 cells].lld:pubmed
pubmed-article:11721388pubmed:affiliationShanghai Institute of Hematology, Laboratory of Leukemia Research, Renji Hospital, Shanghai Second Medical University, Shanghai 200001.lld:pubmed
pubmed-article:11721388pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11721388pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:11721388pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed